首页 正文

Reprioritizing Risk and Benefit: The Future of Study Design in Early-Phase Cancer Research

{{output}}
The scientific purpose of phase I trials is to determine the maximum tolerated dose and/or optimal biological dose of experimental agents. Yet most participants in phase I oncology trials enroll hoping for direct medical benefit. The most common phase I trial ... ...